Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) — Strategic Asset Allocation Index
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) has a Strategic Asset Allocation Index of 45.2% as of June 2023. Strategic assets (PP&E of CN¥1.07 Billion plus long-term investments of CN¥-) total CN¥1.07 Billion, measured against net assets of CN¥2.36 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Shanghai Shenqi Pharmaceutical Investmen balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A Strategic Asset Allocation Index (2000–2021)
This chart shows how Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A's Strategic Asset Allocation Index has evolved across 22 annual periods from 2000 to 2021. As of June 2023, the index stands at 45.2%, representing strategic assets of CN¥1.07 Billion against net assets of CN¥2.36 Billion CNY. For live market cap and overall valuation, see Shanghai Shenqi Pharmaceutical Investmen stock valuation.
Annual Strategic Asset Allocation Index for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (2000–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A from 2000 to 2021, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Shanghai Shenqi Pharmaceutical Investmen shareholders equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 48.8% | CN¥1.17 Billion | CN¥1.17 Billion | CN¥- | CN¥2.39 Billion | ▲ +7.5 pp |
| 2020 | 41.2% | CN¥960.14 Million | CN¥960.14 Million | CN¥- | CN¥2.33 Billion | ▲ +10.2 pp |
| 2019 | 31.0% | CN¥825.07 Million | CN¥825.07 Million | CN¥- | CN¥2.66 Billion | ▲ +0.9 pp |
| 2018 | 30.1% | CN¥783.25 Million | CN¥687.52 Million | CN¥95.73 Million | CN¥2.60 Billion | ▲ +3.7 pp |
| 2017 | 26.5% | CN¥669.73 Million | CN¥556.42 Million | CN¥113.32 Million | CN¥2.53 Billion | ▲ +2.5 pp |
| 2016 | 24.0% | CN¥584.13 Million | CN¥464.65 Million | CN¥119.48 Million | CN¥2.43 Billion | ▼ -0.1 pp |
| 2015 | 24.1% | CN¥550.83 Million | CN¥429.72 Million | CN¥121.11 Million | CN¥2.29 Billion | ▲ +5.5 pp |
| 2014 | 18.6% | CN¥370.69 Million | CN¥370.69 Million | CN¥- | CN¥2.00 Billion | ▼ -5.8 pp |
| 2013 | 24.3% | CN¥440.99 Million | CN¥440.99 Million | CN¥- | CN¥1.81 Billion | ▼ -13.6 pp |
| 2012 | 38.0% | CN¥86.06 Million | CN¥86.06 Million | CN¥- | CN¥226.61 Million | ▼ -1.8 pp |
| 2011 | 39.8% | CN¥84.23 Million | CN¥84.23 Million | CN¥- | CN¥211.50 Million | ▼ -7.8 pp |
| 2010 | 47.6% | CN¥91.61 Million | CN¥91.61 Million | CN¥- | CN¥192.37 Million | ▼ -6.7 pp |
| 2009 | 54.3% | CN¥99.67 Million | CN¥99.67 Million | CN¥- | CN¥183.43 Million | ▲ +2.5 pp |
| 2008 | 51.8% | CN¥108.24 Million | CN¥108.24 Million | CN¥- | CN¥208.82 Million | ▼ -5.7 pp |
| 2007 | 57.5% | CN¥117.45 Million | CN¥117.45 Million | CN¥- | CN¥204.29 Million | ▼ -9.2 pp |
| 2006 | 66.7% | CN¥125.64 Million | CN¥125.64 Million | CN¥- | CN¥188.49 Million | ▼ -5.8 pp |
| 2005 | 72.5% | CN¥134.05 Million | CN¥134.05 Million | CN¥- | CN¥184.92 Million | ▼ -7.3 pp |
| 2004 | 79.8% | CN¥140.65 Million | CN¥140.65 Million | CN¥- | CN¥176.21 Million | ▲ +51.3 pp |
| 2003 | 28.5% | CN¥42.78 Million | CN¥42.78 Million | CN¥- | CN¥150.23 Million | ▼ -8.1 pp |
| 2002 | 36.6% | CN¥53.47 Million | CN¥53.47 Million | CN¥- | CN¥146.14 Million | ▲ +28.2 pp |
| 2001 | 8.4% | CN¥21.17 Million | CN¥21.17 Million | CN¥- | CN¥251.84 Million | ▼ -14.5 pp |
| 2000 | 23.0% | CN¥82.89 Million | CN¥82.89 Million | CN¥- | CN¥361.16 Million | — |